233 related articles for article (PubMed ID: 12941145)
1. Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.
Vajdy M; Singh M; Ugozzoli M; Briones M; Soenawan E; Cuadra L; Kazzaz J; Ruggiero P; Peppoloni S; Norelli F; del Giudice G; O'Hagan D
Immunology; 2003 Sep; 110(1):86-94. PubMed ID: 12941145
[TBL] [Abstract][Full Text] [Related]
2. Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations.
Taylor JM; Ziman ME; Fong J; Solnick JV; Vajdy M
Infect Immun; 2007 Jul; 75(7):3462-9. PubMed ID: 17502399
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
Nyström J; Raghavan S; Svennerholm AM
Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
[TBL] [Abstract][Full Text] [Related]
5. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.
Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ
Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169
[TBL] [Abstract][Full Text] [Related]
6. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.
Howe SE; Konjufca VH
PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.
Malfertheiner P; Schultze V; Rosenkranz B; Kaufmann SH; Ulrichs T; Novicki D; Norelli F; Contorni M; Peppoloni S; Berti D; Tornese D; Ganju J; Palla E; Rappuoli R; Scharschmidt BF; Del Giudice G
Gastroenterology; 2008 Sep; 135(3):787-95. PubMed ID: 18619971
[TBL] [Abstract][Full Text] [Related]
9. The design of vaccines against Helicobacter pylori and their development.
Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
[TBL] [Abstract][Full Text] [Related]
10. Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery.
Goodsell A; Zhou F; Gupta S; Singh M; Malyala P; Kazzaz J; Greer C; Legg H; Tang T; Zur Megede J; Srivastava R; Barnett SW; Donnelly JJ; Luciw PA; Polo J; O'Hagan DT; Vajdy M
Immunology; 2008 Mar; 123(3):378-89. PubMed ID: 17944930
[TBL] [Abstract][Full Text] [Related]
11. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
[TBL] [Abstract][Full Text] [Related]
12. Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.
Guy B; Fourage S; Hessler C; Sanchez V; Millet MJ
Clin Diagn Lab Immunol; 1998 Sep; 5(5):732-6. PubMed ID: 9729544
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance.
Bakke H; Lie K; Haugen IL; Korsvold GE; Høiby EA; Naess LM; Holst J; Aaberge IS; Oftung F; Haneberg B
Infect Immun; 2001 Aug; 69(8):5010-5. PubMed ID: 11447180
[TBL] [Abstract][Full Text] [Related]
14. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
15. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
16. Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen.
Kanellos TS; Byarugaba DK; Russell PH; Howard CR; Partidos CD
Immunol Lett; 2000 Nov; 74(3):215-20. PubMed ID: 11064104
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
Nyström J; Svennerholm AM
Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
[TBL] [Abstract][Full Text] [Related]
18. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
20. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
